Abstract
The present work reports the effect of conjugation of the anticarcinogenic and antitumor soybean Bowman-Birk protease inhibitor (BBI) with amphiphilic block copolymer of ethylene oxide and propylene oxide (PEO-PPO) as well as with monoclonal antibody via clinical dextran (D) on tumor-targeted delivery of BBI.
Original language | English (US) |
---|---|
Pages (from-to) | 303-308 |
Number of pages | 6 |
Journal | Journal of Controlled Release |
Volume | 74 |
Issue number | 1-3 |
DOIs | |
State | Published - Jul 6 2001 |
Externally published | Yes |
Keywords
- Ethylene oxide and propylene oxide block copolymer
- Immunoconjugate
- Soybean Bowman-Birk protease inhibitor (BBI)
- Targeting
- Tumor
ASJC Scopus subject areas
- Pharmaceutical Science